Breast Pathology Flashcards
What is the anatomical composition of the breast?
A modified sweat gland adapted for milk production.
How are breast ducts and glands organized?
Into small subdivisions called lobules.
What are the primary components of the breast stroma?
Mostly fat plus a network of thin fibrous ligaments.
What hormones affect breast tissue and how?
Estrogen and progesterone; they account for the increase in size at puberty and changes during the menstrual cycle.
What is the primary lymphatic drainage pathway for the breast?
To the axillary nodes.
Where do lymphatics from the medial aspect of the breast drain?
Into the internal mammary nodes.
What changes occur in the breast during pregnancy?
Milk-secreting cells develop (prolactin-induced) and secretion begins immediately after birth; glandular epithelium atrophies if breastfeeding fails to occur.
What is acute mastitis and what are its common causes?
Acute infection of the breast, typically caused by staphylococcus or streptococcus organisms.
How does staphylococcus infection in the breast typically present?
Produces an abscess.
How does streptococcus infection in the breast typically present?
Produces generalized swelling, tenderness, and pain.
What is chronic breast inflammation often associated with?
Often associated with fibrocystic change.
What is fat necrosis of the breast and what can cause it?
An unusual type of necrosis occurring only in fat, often due to trauma.
What is fibrocystic change in the breast?
Consists of fibrosis, chronic inflammation, and cystic dilation of breast ducts.
What are the classifications of fibrocystic change?
Non-proliferative and proliferative (usual and atypical).
How common is fibrocystic change in women?
50% of women have some degree of fibrocystic change, but only about one-quarter of these patients have any symptoms.
What are the usual characteristics of a fibroadenoma?
A benign neoplastic lesion that is well-circumscribed and encapsulated.
What is a phyllodes tumor and how does it differ from a fibroadenoma?
A spectrum from benign to borderline to malignant, differing in histological features from a fibroadenoma.
What are the differences between fibroadenoma and fibrocystic change?
Fibroadenoma is a well-circumscribed, encapsulated, benign neoplastic lesion; fibrocystic change is a diffuse, non-neoplastic lesion, often cystic and associated with inflammation.
What are the common malignant tumors of the breast?
Invasive ductal carcinoma and invasive lobular carcinoma.
What is the most common subtype of invasive ductal carcinoma?
No specific type (NST).
What is the typical origin of breast cancer?
From the inner lining of breast ducts (ductal carcinomas) or breast lobules (lobular carcinomas).
What are the key epidemiological facts about breast cancer?
The most commonly diagnosed cancer in women worldwide and the 5th leading cause of cancer death.
What are some key risk factors for breast cancer?
Female sex, increasing age, race (higher incidence in Caucasians), increased exposure to estrogen, higher socioeconomic status, significant radiation exposure, family history, BRCA1 & 2 gene mutations, smoking, alcohol intake, sedentary lifestyle, diet.
What are some common clinical presentations of breast cancer?
Small breast lump, breast mass with or without skin changes, peri-areolar eczematous changes, bloody nipple discharge, enlarged breast with signs of inflammation, axillary lump, distant metastases.
What is the “triple test” in diagnosing breast lesions?
Imaging, clinical examination, and biopsy.
What imaging techniques are critical for diagnosing breast disease?
Mammography, ultrasonography, and MRI.
What is the purpose of a vacuum-assisted core biopsy?
To obtain tissue samples for diagnosis.
What are the World Health Organization’s recommendations for mammography screening programs?
It needs to cover at least 70% of the population at risk.
At what age is annual screening mammography recommended for the general population?
Starting at age 40 for the general population.
What is the role of molecular classification in breast cancer?
Guides treatment use and results in targeted use of specific treatments, reducing toxicity.
What are the five IHC markers used for molecular classification of breast cancer?
ER, PR, HER2, CK5/6, EGFR.
What are the biomarker profiles for Luminal A breast cancer?
ER+, PR+, HER2-, Ki67 (<14%).
What are the biomarker profiles for Luminal B breast cancer?
ER+, PR+, HER2+, or ER+, PR+, HER2-, Ki67 (>14%).
What are the biomarker profiles for HER2 breast cancer?
ER-, PR-, HER2+.
What are the biomarker profiles for triple-negative breast cancer?
ER-, PR-, HER2-, CK5/6+, EGFR+.
What are the typical metastasis sites for Luminal A breast cancer?
Most commonly to bone; least likely to brain, liver, or lung.
What treatments are effective for Luminal A breast cancer?
Good response to hormonal therapy.
What are the typical metastasis sites for Luminal B breast cancer?
Most commonly to bone, followed by liver and lung.
What treatments are effective for Luminal B breast cancer?
Benefits from chemotherapy and hormonal therapy.
What are the typical metastasis sites for HER2 breast cancer?
Most commonly to bone, brain, liver, and lung.